Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRegional Reit Regulatory News (RGL)

Share Price Information for Regional Reit (RGL)

Share Price is delayed by 15 minutes
Get Live Data
90.40    2.00 (2.26%)
Bid:
88.10
Ask:
93.00
Spread: 4.90 (5.562%)
Market Cap: £146.53m
RGL Live PriceLast checked at - London Stock Exchange

Intraday Regional Reit Share Chart

Response to Press Speculation

12 Mar 2024 07:00

RNS Number : 4256G
Regional REIT Limited
12 March 2024
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE FOR INFORMATION PURPOSES ONLY AND DO NOT CONSTITUTE AN OFFER OF SECURITIES IN ANY JURISDICTION.

This announcement contains certain inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

12 March 2024

REGIONAL REIT LIMITED

("Regional REIT" or the "Company", together with its subsidiaries the "Group")

Response to press speculation

Further to the Q4 trading update published on 2 February 2024 and the dividend declaration announcement on 22 February 2024 (together, the "Previous Announcements"), Regional REIT (LSE: RGL) notes the recent press speculation regarding the possibility of the Company undertaking an equity capital raise of around £75 million.

As indicated in the Previous Announcements, the Company is actively exploring a range of refinancing options, including debt and/or equity, in respect of the existing £50 million retail bond (the "Retail Bond") given its maturity date in August 2024.  

The Company confirms that significant preparatory work has been undertaken to date in respect of both the debt and equity options, which remain under active consideration.

In the event that the Company proceeds with an equity issue, the Company expects that it would be at a material discount to the Company's current share price and would be subject to, amongst other things, shareholder approval.

The Company continues to consider its options and a further announcement will be made when appropriate.

- ENDS -

 

Enquiries:

 

Regional REIT Limited

 

Press enquiries through Buchanan

ARA Europe Private Markets Limited

Tel: +44 (0) 20 7845 6100

Investment Adviser to the Group

Adam Dickinson, Investor Relations

London & Scottish Property Investment Management 

Tel: +44 (0) 141 248 4155

Asset Manager to the Group

Stephen Inglis

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Financial PR

Charles Ryland, Henry Wilson, George Beale

 

About Regional REIT

Regional REIT Limited ("Regional REIT" or the "Company") and its subsidiaries (the "Group") is a United Kingdom ("UK") based real estate investment trust that launched in November 2015. It is managed by London & Scottish Property Investment Management Limited, the Asset Manager, and ARA Europe Private Markets Limited, the Investment Adviser.

Regional REIT's commercial property portfolio is comprised wholly of income producing UK assets and, predominantly, of offices located in the regional centres outside of the M25 motorway. The portfolio is geographically diversified, with 144 properties and 978 occupiers as at 31 December 2023, with a valuation of c.£700.7m.

Regional REIT pursues its investment objective by investing in, actively managing and disposing of regional core and core plus property assets. It aims to deliver an attractive total return to its Shareholders, targeting greater than 10% per annum, with a strong focus on income supported by additional capital growth prospects.

The Company's shares were admitted to the Official List of the UK's Financial Conduct Authority and to trading on the London Stock Exchange on 6 November 2015. For more information, please visit the Group's website at www.regionalreit.com .

Cautionary Statement

This announcement has been prepared solely to provide additional information to Shareholders to assess the Group's performance in relation to its operations and growth potential. The announcement should not be relied upon by any other party or for any other reason. Any forward looking statements made in this announcement are done so by the Directors in good faith based on the information available to them up to the time of their approval of this document. However, such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward-looking information.

ESMA Legal Entity Identifier ("LEI"): 549300D8G4NKLRIKBX73

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCDGGDXSXBDGSB
Date   Source Headline
19th Jul 20243:44 pmRNSNotice of AGM
18th Jul 20242:24 pmRNSResult of EGM
28th Jun 20243:21 pmRNSDirector/PDMR Shareholding
27th Jun 202411:00 amRNSPublication of Prospectus
27th Jun 20247:00 amRNSUnderwritten £110.5m Capital Raise & Notice of EGM
22nd May 20247:00 amRNSQ1 2024 Trading Update, Dividend and EPC Update
1st May 20247:00 amRNSPositive Letting Update
22nd Apr 20245:36 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSPositive Letting Update
26th Mar 20247:00 amRNS2023 Full Year Results
12th Mar 20247:00 amRNSResponse to Press Speculation
22nd Feb 20247:00 amRNSDividend Declaration
2nd Feb 20247:00 amRNSQ4 23 Valuation and Portfolio Update
9th Nov 20237:00 amRNSQ3 23 Trading Update, Dividend and ESG Update
9th Nov 20237:00 amRNSOffice Sale 26.3% above Valuation
31st Oct 20237:00 amRNSNorfolk House – Positive Letting Update
12th Oct 202312:29 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSAppointment of ARA Europe as Investment Adviser
3rd Oct 20237:15 amEQSRegional REIT: Dividend rebase pragmatic and sustainable
12th Sep 20237:00 amRNSQ2 2023 Dividend Declaration
12th Sep 20237:00 amRNS2023 Half Year Results
11th Aug 202311:34 amRNSReplacement - Released in Error
11th Aug 20237:00 amRNSEdison issues update on Target Healthcare REIT
9th Jun 20237:00 amRNSUpdate on Office Occupancy
25th May 20233:14 pmRNSResult of AGM
24th May 20237:00 amRNSTrading Update and Dividend Declaration
14th Apr 20234:00 pmRNSQuotedData's Weekly News & Interview
13th Apr 20237:00 amRNSAsset Manager Update
30th Mar 20239:30 amRNSAsset Manager Update
28th Mar 20237:00 amRNSFinal Results
23rd Feb 20237:00 amRNSQ4 22 Divi, Letting Update & FY22 Valuation
14th Feb 20237:00 amRNSPositive Update on Office Use
13th Dec 20227:00 amRNSPositive Lettings Update
11th Nov 202210:05 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSQ3 2022 Trading Update and Dividend Declaration
20th Oct 20224:13 pmRNSDirector/PDMR Shareholding
15th Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSDividend Declaration
15th Aug 20225:03 pmRNSDirector/PDMR Shareholding
15th Aug 20225:01 pmRNSDirector/PDMR Shareholding
15th Aug 20224:58 pmRNSDirector/PDMR Shareholding
15th Aug 202211:58 amRNSDirector/PDMR Shareholding
12th Aug 20224:45 pmRNSDirector/PDMR Shareholding
12th Aug 20224:44 pmRNSDirector/PDMR Shareholding
12th Aug 20224:42 pmRNSDirector/PDMR Shareholding
12th Aug 20224:41 pmRNSDirector/PDMR Shareholding
7th Jul 202212:01 pmRNSDirector/PDMR Shareholding
7th Jul 202211:35 amRNSDirector/PDMR Shareholding
7th Jul 202211:35 amRNSDirector/PDMR Shareholding
4th Jul 20225:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.